7.600
+0,00%
2026-10-15
Fundamental Analysis
54 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +97.8% | -29.1% | 1 / 3 | +142.8% | +0.15 pp | -0.97 pp | +8.0% | 0.91 | 6.66 | 259 | +142,8% | 11,1 | +97,8% | 6.66 | 11.21 | −40,6% |
| Pts | 12 | 0 | 4 | 12 | 8 | 4 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 7.600 (close price on 2026-10-15)EPS (TTM): 1.141
Financial charts
1.Revenue & growth
VND bn253Q2/26
1.Revenue & growth
VND bn253Q2/26
2.Profit & growth
VND bn11,1Q2/26
3.Profit mix (Penman)
VND bn23,8Q2/26
4.Margins & cost structure
%6.1%Q2/26
5.Returns & cash cycle
% · days4.4%Q2/26
6.Earnings quality & cash
VND bn38,6Q2/26
7.Asset structure
VND bn527Q2/26
8.Funding & debt health
VND bn · times527Q2/26
9.Revenue backlog
VND bn0,05Q2/26
10.Valuation
times · %6,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %671Q2/26
Adjusted EPS growth, latest quarter
97.8%
Average adjusted EPS growth, 3 quarters
-29.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26